{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:30:21Z","timestamp":1790361021309,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12105-021-01333-5","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T05:02:52Z","timestamp":1622437372000},"page":"1235-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gingival Leukoplakia: Hyperkeratosis with Epithelial Atrophy Is A Frequent Histopathologic Finding"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9855-4321","authenticated-orcid":false,"given":"Lama","family":"Alabdulaaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Almazyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Bin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"1333_CR1","first-page":"112","volume-title":"WHO classification of head and neck tumours","author":"J Reibel","year":"2017","unstructured":"Reibel J, Gale N, Hille J, Hunt J, Lingen M, Muller S, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: El-Naggar A, Chan J, Grandis J, Takata T, Slootweg P, editors., et al., WHO classification of head and neck tumours. Lyon: IARC; 2017. p. 112\u20135."},{"issue":"1","key":"1333_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaad.2007.07.011","volume":"58","author":"E Natarajan","year":"2008","unstructured":"Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): a distinct clinicopathologic entity. J Am Acad Dermatol. 2008;58(1):151\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2007.07.011.","journal-title":"J Am Acad Dermatol"},{"key":"1333_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12105-020-01151-1","volume":"14","author":"A Almazyad","year":"2020","unstructured":"Almazyad A, Li C, Woo S. Benign alveolar ridge keratosis: clinical and histopathologic analysis of 167 cases. Head Neck Pathol. 2020;14:915\u201322.","journal-title":"Head Neck Pathol."},{"issue":"3","key":"1333_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12105-019-01020-6","volume":"13","author":"SB Woo","year":"2019","unstructured":"Woo SB. Oral epithelial dysplasia and premalignancy. Head Neck Pathol. 2019;13(3):423\u201339. https:\/\/doi.org\/10.1007\/s12105-019-01020-6.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"1333_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.oooo.2013.09.017","volume":"117","author":"F Dost","year":"2014","unstructured":"Dost F, Le Cao K, Ford PJ, Ades C, Farah CS. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):343\u201352. https:\/\/doi.org\/10.1016\/j.oooo.2013.09.017.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"1333_CR6","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1111\/odi.12095","volume":"20","author":"E Brouns","year":"2014","unstructured":"Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19-24. https:\/\/doi.org\/10.1111\/odi.12095.","journal-title":"Oral Dis"},{"issue":"4","key":"1333_CR7","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.4317\/medoral.22326","volume":"23","author":"P Gandara-Vila","year":"2018","unstructured":"Gandara-Vila P, Perez-Sayans M, Suarez-Penaranda JM, Gallas-Torreira M, Somoza-Martin J, Reboiras-Lopez MD, et al. Survival study of leukoplakia malignant transformation in a region of northern Spain. Med Oral Patol Oral Cir Bucal. 2018;23(4):e413\u201320. https:\/\/doi.org\/10.4317\/medoral.22326.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1333_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-020-01216-1","author":"CC Li","year":"2020","unstructured":"Li CC, Almazrooa S, Carvo I, Salcines A, Woo SB. Architectural alterations in oral epithelial dysplasia are similar in unifocal and proliferative leukoplakia. Head Neck Pathol. 2020. https:\/\/doi.org\/10.1007\/s12105-020-01216-1.","journal-title":"Head Neck Pathol"},{"issue":"6","key":"1333_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.oooo.2014.09.016","volume":"118","author":"SB Woo","year":"2014","unstructured":"Woo SB, Grammer RL, Lerman MA. Keratosis of unknown significance and leukoplakia: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(6):713\u201324. https:\/\/doi.org\/10.1016\/j.oooo.2014.09.016.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1333_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1472-6831-14-99","volume":"14","author":"YY Wang","year":"2014","unstructured":"Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14:99. https:\/\/doi.org\/10.1186\/1472-6831-14-99.","journal-title":"BMC Oral Health"},{"issue":"9","key":"1333_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bjoms.2015.08.268","volume":"53","author":"ML Goodson","year":"2015","unstructured":"Goodson ML, Sloan P, Robinson CM, Cocks K, Thomson PJ. Oral precursor lesions and malignant transformation\u2013who, where, what, and when? Br J Oral Maxillofac Surg. 2015;53(9):831\u20135. https:\/\/doi.org\/10.1016\/j.bjoms.2015.08.268.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"7","key":"1333_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/jop.12899","volume":"48","author":"K Shearston","year":"2019","unstructured":"Shearston K, Fateh B, Tai S, Hove D, Farah CS. Malignant transformation rate of oral leukoplakia in an Australian population. J Oral Pathol Med. 2019;48(7):530\u20137. https:\/\/doi.org\/10.1111\/jop.12899.","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"1333_CR13","doi-asserted-by":"publisher","first-page":"e0225682","DOI":"10.1371\/journal.pone.0225682","volume":"14","author":"J Sundberg","year":"2019","unstructured":"Sundberg J, Korytowska M, Holmberg E, Bratel J, Wallstrom M, Kjellstrom E, et al. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study. PLoS ONE. 2019;14(12):e0225682. https:\/\/doi.org\/10.1371\/journal.pone.0225682.","journal-title":"PLoS ONE"},{"key":"1333_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz238","author":"AK Chaturvedi","year":"2019","unstructured":"Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study. J Natl Cancer Inst. 2019. https:\/\/doi.org\/10.1093\/jnci\/djz238.","journal-title":"J Natl Cancer Inst"},{"key":"1333_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-020-03322-4","author":"PR Jayasooriya","year":"2020","unstructured":"Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S. Malignant transformation of oral leukoplakia: a follow-up study. Clin Oral Investig. 2020. https:\/\/doi.org\/10.1007\/s00784-020-03322-4.","journal-title":"Clin Oral Investig"},{"key":"1333_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oraloncology.2018.10.021","volume":"87","author":"SL Chuang","year":"2018","unstructured":"Chuang SL, Wang CP, Chen MK, Su WW, Su CW, Chen SL, et al. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: a prospective cohort study of Taiwanese nationwide oral cancer screening program. Oral Oncol. 2018;87:58\u201363. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.10.021.","journal-title":"Oral Oncol"},{"issue":"5","key":"1333_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.oraloncology.2005.08.011","volume":"42","author":"P Holmstrup","year":"2006","unstructured":"Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461\u201374. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.08.011.","journal-title":"Oral Oncol"},{"issue":"5","key":"1333_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcms.2015.03.011","volume":"43","author":"A Mogedas-Vegara","year":"2015","unstructured":"Mogedas-Vegara A, Hueto-Madrid JA, Chimenos-Kustner E, Bescos-Atin C. The treatment of oral leukoplakia with the CO2 laser: a retrospective study of 65 patients. J Craniomaxillofac Surg. 2015;43(5):677\u201381. https:\/\/doi.org\/10.1016\/j.jcms.2015.03.011.","journal-title":"J Craniomaxillofac Surg"},{"issue":"9","key":"1333_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1600-0714.2012.01167.x","volume":"41","author":"Y Kuribayashi","year":"2012","unstructured":"Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 2012;41(9):682\u20138. https:\/\/doi.org\/10.1111\/j.1600-0714.2012.01167.x.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"1333_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.oooo.2018.02.012","volume":"125","author":"S Muller","year":"2018","unstructured":"Muller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):591\u2013602. https:\/\/doi.org\/10.1016\/j.oooo.2018.02.012.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"1333_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/bjd.12853","volume":"170","author":"M Pentenero","year":"2014","unstructured":"Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br J Dermatol. 2014;170(5):1039\u201347. https:\/\/doi.org\/10.1111\/bjd.12853.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1333_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1079-2104(97)90062-7","volume":"84","author":"S Silverman","year":"1997","unstructured":"Silverman S, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 1997;84(2):154\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"7","key":"1333_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1034\/j.1600-0714.2003.00167.x","volume":"32","author":"J Bagan","year":"2003","unstructured":"Bagan J, Jimenez Y, Sanchis J, Poveda R, Millan M, Murillo J, et al. Proliferative Verrucous Leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med. 2003;32(7):379\u201382.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"1333_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.14219\/jada.archive.2007.0236","volume":"138","author":"AC Chi","year":"2007","unstructured":"Chi AC, Lambert PR 3rd, Pan Y, Li R, Vo DT, Edwards E, et al. Is alveolar ridge keratosis a true leukoplakia?: a clinicopathologic comparison of 2,153 lesions. J Am Dent Assoc. 2007;138(5):641\u201351. https:\/\/doi.org\/10.14219\/jada.archive.2007.0236.","journal-title":"J Am Dent Assoc"},{"issue":"1","key":"1333_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12105-018-0986-3","volume":"13","author":"S Muller","year":"2019","unstructured":"Muller S. Frictional keratosis, contact keratosis and smokeless tobacco keratosis: features of reactive white lesions of the oral mucosa. Head Neck Pathol. 2019;13(1):16\u201324. https:\/\/doi.org\/10.1007\/s12105-018-0986-3.","journal-title":"Head Neck Pathol"},{"issue":"8","key":"1333_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1600-0714.2009.00790.x","volume":"38","author":"YP Wang","year":"2009","unstructured":"Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, et al. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009;38(8):651\u20136. https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00790.x.","journal-title":"J Oral Pathol Med"},{"key":"1333_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-020-01262-9","author":"LDR Thompson","year":"2021","unstructured":"Thompson LDR, Fitzpatrick SG, Muller S, Eisenberg E, Upadhyaya JD, Lingen MW, et al. Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting. Head Neck Pathol. 2021. https:\/\/doi.org\/10.1007\/s12105-020-01262-9.","journal-title":"Head Neck Pathol"},{"issue":"10","key":"1333_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","volume":"36","author":"S Warnakulasuriya","year":"2007","unstructured":"Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575\u201380. https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00582.x.","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"1333_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jop.12726","volume":"47","author":"FW Mello","year":"2018","unstructured":"Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633\u201340. https:\/\/doi.org\/10.1111\/jop.12726.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"1333_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12105-018-0893-7","volume":"12","author":"JD Upadhyaya","year":"2018","unstructured":"Upadhyaya JD, Fitzpatrick SG, Islam MN, Bhattacharyya I, Cohen DM. A retrospective 20-year analysis of proliferative verrucous leukoplakia and its progression to malignancy and association with high-risk human papillomavirus. Head Neck Pathol. 2018;12(4):500\u201310. https:\/\/doi.org\/10.1007\/s12105-018-0893-7.","journal-title":"Head Neck Pathol"},{"issue":"s1","key":"1333_CR31","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1038\/modpathol.2016.121","volume":"30","author":"S Muller","year":"2017","unstructured":"Muller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30(s1):S54\u201367. https:\/\/doi.org\/10.1038\/modpathol.2016.121.","journal-title":"Mod Pathol"},{"issue":"4","key":"1333_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.oooo.2013.12.413","volume":"117","author":"SG Fitzpatrick","year":"2014","unstructured":"Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511\u201320. https:\/\/doi.org\/10.1016\/j.oooo.2013.12.413.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"1333_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12105-019-01006-4","volume":"13","author":"LA Davidova","year":"2019","unstructured":"Davidova LA, Fitzpatrick SG, Bhattacharyya I, Cohen DM, Islam MN. Lichenoid characteristics in premalignant verrucous lesions and verrucous carcinoma of the oral cavity. Head Neck Pathol. 2019;13(4):573\u20139. https:\/\/doi.org\/10.1007\/s12105-019-01006-4.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"1333_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. 2013;13(2):88\u2013100. https:\/\/doi.org\/10.1038\/nri3384.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1333_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1053\/j.seminoncol.2015.05.003","volume":"42","author":"D Pardoll","year":"2015","unstructured":"Pardoll D. Cancer and the immune system: basic concepts and targets for intervention. Semin Oncol. 2015;42(4):523\u201338. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.05.003.","journal-title":"Semin Oncol"},{"issue":"2","key":"1333_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","volume":"29","author":"M Brandwein-Gensler","year":"2005","unstructured":"Brandwein-Gensler M, Teixeira M, Ming Lewis C, Lee B, Rolnitzky L, Hille J, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167\u201378.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1333_CR37","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41598-020-63148-8","volume":"10","author":"L Li","year":"2020","unstructured":"Li L, Wang XL, Lei Q, Sun CZ, Xi Y, Chen R, et al. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer. Sci Rep. 2020;10(1):6395. https:\/\/doi.org\/10.1038\/s41598-020-63148-8.","journal-title":"Sci Rep"},{"issue":"26","key":"1333_CR38","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus Ipilimumab in advanced Melanoma. N Engl J Med. 2015;372(26):2521\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1503093.","journal-title":"N Engl J Med"},{"issue":"19","key":"1333_CR39","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375(19):1823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1606774.","journal-title":"N Engl J Med"},{"key":"1333_CR40","unstructured":"FDA. FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma. 2019. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pembrolizumab-first-line-treatment-head-and-neck-squamous-cell-carcinoma."},{"issue":"10212","key":"1333_CR41","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/s0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington K, Greil R, Souli\u00e8res D, Tahara M, de Castro G, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394(10212):1915\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(19)32591-7.","journal-title":"Lancet"},{"issue":"5","key":"1333_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"6","key":"1333_CR43","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.4317\/jced.57091","volume":"12","author":"A Rubert","year":"2020","unstructured":"Rubert A, Bag\u00e1n L, Bag\u00e1n JV. Oral leukoplakia, a clinical-histopathological study in 412 patients. J Clin Exp Dent. 2020;12(6):e540\u20136. https:\/\/doi.org\/10.4317\/jced.57091.","journal-title":"J Clin Exp Dent"},{"key":"1333_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/2057178x16654704","author":"T Nagao","year":"2016","unstructured":"Nagao T, Warnakulasuriya S, Hasegawa S, Sakuma H, Miyabe S, Komaki K, et al. Elucidating risk factors for oral leukoplakia affecting gingivae in Japanese subjects. Transl Res Oral Oncol. 2016. https:\/\/doi.org\/10.1177\/2057178x16654704.","journal-title":"Transl Res Oral Oncol"},{"issue":"6","key":"1333_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.oooo.2017.12.011","volume":"125","author":"PM Speight","year":"2018","unstructured":"Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612\u201327. https:\/\/doi.org\/10.1016\/j.oooo.2017.12.011.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1333_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-0714.2006.00491.x","volume":"36","author":"S Hsue","year":"2007","unstructured":"Hsue S, Wang W, Chen C, Lin C, Chen Y, Lin L. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36:25\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"1333_CR47","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/odi.13155","volume":"25","author":"A Villa","year":"2019","unstructured":"Villa A, Hanna GJ, Kacew A, Frustino J, Hammerman PS, Woo SB. Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Dis. 2019;25(7):1707\u201314. https:\/\/doi.org\/10.1111\/odi.13155.","journal-title":"Oral Dis"},{"issue":"7536","key":"1333_CR48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Cancer Genome Atlas N","year":"2015","unstructured":"Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576\u201382. https:\/\/doi.org\/10.1038\/nature14129.","journal-title":"Nature."},{"issue":"7","key":"1333_CR49","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/odi.13156","volume":"25","author":"CS Farah","year":"2019","unstructured":"Farah CS, Fox SA. Dysplastic oral leukoplakia is molecularly distinct from leukoplakia without dysplasia. Oral Dis. 2019;25(7):1715\u201323. https:\/\/doi.org\/10.1111\/odi.13156.","journal-title":"Oral Dis"},{"issue":"8","key":"1333_CR50","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-13-0001","volume":"6","author":"M Sperandio","year":"2013","unstructured":"Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, et al. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila). 2013;6(8):822\u201331. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0001.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1333_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13797","author":"EW Odell","year":"2021","unstructured":"Odell EW. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis. 2021. https:\/\/doi.org\/10.1111\/odi.13797.","journal-title":"Oral Dis"},{"issue":"20","key":"1333_CR52","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMp1508811","volume":"373","author":"B Vogelstein","year":"2015","unstructured":"Vogelstein B, Kinzler KW. The path to cancer \u2013three strikes and you\u2019re out. N Engl J Med. 2015;373(20):1895\u20138. https:\/\/doi.org\/10.1056\/NEJMp1508811.","journal-title":"N Engl J Med"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01333-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-021-01333-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01333-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:40:23Z","timestamp":1638340823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-021-01333-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1007\/s12105-021-01333-5","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"No conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data included in this study includes retrospective histopathological assessment of specimens obtained for diagnostic purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}